{"id":7818,"date":"2026-06-01T14:10:12","date_gmt":"2026-06-01T18:10:12","guid":{"rendered":"https:\/\/cqdm.org\/?p=7818"},"modified":"2026-06-01T14:22:31","modified_gmt":"2026-06-01T18:22:31","slug":"welcome-to-our-newest-network-member","status":"publish","type":"post","link":"https:\/\/cqdm.org\/en\/news-and-events\/welcome-to-our-newest-network-member\/","title":{"rendered":"Welcome to our newest ‘network’ member"},"content":{"rendered":"\n

We are thrilled to welcome new network members<\/a> to our community.

CTI Life Sciences<\/strong> \u2013 A venture capital firm specialized in biotechnology, CTI supports the creation and growth of innovative life sciences companies. Website: www.ctisciences.com<\/a>

MISO Chip<\/strong> \u2013 A Montreal-based company developing a tumor-on-a-chip platform that enables anticancer agents to be tested on human tumor tissues while preserving their native microenvironment. Website: misochip.com<\/a>

RayaBiotec<\/strong> \u2013 An agri-biotech company offering applied molecular, cellular, and protein diagnostic services to support innovation in animal health and agriculture. Website: www.rayabiotec.com<\/a>

Royalmount Biopharma Services<\/strong> \u2013 A division of Pharmascience, Royalmount supports therapeutic development stakeholders with advanced expertise in bioanalysis, biomarkers, immunogenicity, and pharmaceutical development. Website: rmtbiopharma.com\/en<\/a>

sevenTM<\/strong> \u2013 sevenTM helps pharmaceutical and biotechnology companies identify and validate more promising candidates, faster, while prioritizing reduced toxicity and side effects. Website: www.seventm.com<\/a>

Skillpad<\/strong> \u2013 Skillpad provides digital GxP training solutions for life sciences teams, helping strengthen skills, compliance, and operational performance. Website: www.skillpad.com<\/a>

TheraVac Bio<\/strong> \u2013 TheraVac develops innovative immunotherapies and vaccines for chronic and neurodegenerative diseases, including Alzheimer\u2019s disease. Website: theravacbio.com<\/a>

X-Chem<\/strong> \u2013 X-Chem leverages an integrated platform combining DNA-encoded libraries, medicinal chemistry, modeling, and AI to accelerate the discovery of small-molecule therapeutics. Website: www.x-chemrx.com<\/a>

We are proud to count them among our community and look forward to the new collaborations, strategic connections, and business opportunities their presence will help generate across the network.

Being part of our network means joining a dynamic ecosystem, increasing your visibility, building relationships with key industry players, and gaining access to concrete opportunities for collaboration and growth.

Would you like to expand your network, raise your profile, and help advance innovation in the life sciences sector? Become a network member <\/a>and join a community that is driving the industry forward.<\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

We are thrilled to welcome new network members to our community.CTI Life Sciences \u2013 A venture capital firm specialized in biotechnology, CTI supports the creation and growth of innovative life sciences companies. Website: www.ctisciences.comMISO Chip \u2013 A Montreal-based company developing a tumor-on-a-chip platform that enables anticancer agents to be tested on human tumor tissues while…<\/p>\n","protected":false},"author":5,"featured_media":7819,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7818","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-our-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts\/7818","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/comments?post=7818"}],"version-history":[{"count":1,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts\/7818\/revisions"}],"predecessor-version":[{"id":7821,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts\/7818\/revisions\/7821"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/media\/7819"}],"wp:attachment":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/media?parent=7818"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/categories?post=7818"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/tags?post=7818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}